Obstetric Anaesthesia And Analgesia Month Attributes - in COVID-19 (OBAAMA-COV)

October 21, 2021 updated by: Petr Štourač, MD, Brno University Hospital

A National Survey on Obstetric Anesthesia and Analgesia Care: Obstetric Anaesthesia And Analgesia Month Attributes - in COVID-19 (OBAAMA-COV)

A national survey of current practices, preferred drug and technique choices for obstetric anesthesia and analgesia and to evaluate the impact of COVID-19 pandemic on obstetric anesthesia and analgesia in Czech Republic and Slovak Republic

Study Overview

Status

Not yet recruiting

Detailed Description

A one month-long project monitoring an obstetric anesthesia practices in obstetric/anesthesia departments throughout the Czech Republic and Slovak Republic.

Electronic Case Report Form (eCRF) is used to collect data on all obstetric anesthesia procedures in peripartal period and obstetric and anesthesia complications. All consecutive cases in each participating center during the study period are recorded. Each record is related to parturient and contains the following sections: history, form of labour analgesia, type of anesthesia for Cesarean section and anesthesia in third stage of labor.

Study Type

Observational

Enrollment (Anticipated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • South Moravian Region
      • Brno, South Moravian Region, Czechia, 62500
        • Brno University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women in labor undergoing anesthesia care

Description

Inclusion Criteria:

  • Women in labor undergoing anesthesia care

Exclusion Criteria:

  • not meeting inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Women in labor undergoing anesthesia care
All anesthesia procedures during labor: labor analgesia, anesthesia for Cesarean section, anesthesia for procedures in third stage of labor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A national survey of current practice of obstetric anesthesia and analgesia in Czech Republic and Slovak Republic
Time Frame: Parturition period, up to 24 hours after labor
Monitoring of all obstetric anesthesia procedures in peripartal period and anesthesia complications: history, form of labour analgesia, type of anesthesia for Cesarean section and anesthesia in third stage of labor.
Parturition period, up to 24 hours after labor

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Types of anesthesia a analgesia in peripartal period
Time Frame: Parturition period, up to 24 hours after labor
To describe current practice related to peripartal anesthesia care
Parturition period, up to 24 hours after labor
Complications related to obstetric anesthesia care
Time Frame: Parturition period, up to 24 hours after labor
To describe current practice a complications related to peripartal anesthesia care
Parturition period, up to 24 hours after labor

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2022

Primary Completion (Anticipated)

January 31, 2022

Study Completion (Anticipated)

February 1, 2022

Study Registration Dates

First Submitted

June 2, 2021

First Submitted That Met QC Criteria

June 2, 2021

First Posted (Actual)

June 3, 2021

Study Record Updates

Last Update Posted (Actual)

October 28, 2021

Last Update Submitted That Met QC Criteria

October 21, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstetric Anesthesia Care

Clinical Trials on Obstetric anesthesia and analgesia

Subscribe